All In Biotech

Drug Trial Radar · NCT06430866

Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy

Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 163 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

163

Actual

Start

Sep 12, 2024

Primary completion

Dec 14, 2026

Study completion Dec 14, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
May 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.

Conditions

  • Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)

Interventions

  • ABP 234Drug

    Administered by intravenous (IV) injection.

  • PembrolizumabDrug

    Administered by IV injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Serum Concentration-time Curve (AUC) From Time 0 to 21 Days (AUC21d) Following the First DoseTime frame: 21 days
  2. AUC at Steady State Between Week 16 and Week 19 (AUCtau_ss)Time frame: Weeks 16-19

Locations

128 sites in 18 countries. Site status is shown where the registry gives one.

  • Ionc Instituto Oncologico De Cordoba

    Córdoba, Argentina

  • Fundacion ARS Medica

    San Salvador de Jujuy, Jujuy Province, Argentina

  • Instituto de Oncologia de Rosario

    Rosario, Santa Fe Province, Argentina

  • University Multiprofile Hospital for Active Treatment Sofiamed

    Sofia, Bulgaria

  • K2 Oncology

    Santiago, Chile

  • Icegclinic Research and Care

    Santiago, Chile

  • CDIEM - Centro de Investigacion y Especialidades Medicas

    Providencia, Region Metropolotana, Chile

  • Instituto Oncologico Fundacion Arturo Lopez Perez (FALP)

    Providencia, Santiago Metropolitan, Chile

  • Centro de Oncologia de Precision

    Region Metropolitana, Santiago Metropolitan, Chile

  • Clinica Santa Maria

    Santiago, Santiago Metropolitan, Chile

  • Centro de Investigaciones Clinicas Vina del Mar Ltda.

    Viña Del Mar, Valparaiso, Chile

  • Centro de Investigacin de Enfermedades Respiratorias e Inmunologicas Limitada CIERI

    Viña del Mar, Valparaiso, Chile

  • Clinique Belharra Ramsay Sante

    Bayonne, France

  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre

    Bordeaux, France

  • Centre Francois Baclesse

    Caen, France

  • Hopital Europeen Marseille

    Marseille, France

  • Hopital Bichat, APHP

    Paris, France

  • Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hopital Sainte Musse

    Toulon, France

  • Hopital Robert Schuman

    Vantoux, France

  • LLC Todua Clinic

    Tbilisi, Georgia

  • New Hospitals

    Tbilisi, Georgia

  • Studienzentrum Aschaffenburg

    Aschaffenburg, Germany

  • Kliniken Essen Mitte, Evang. Huyssens-Stiftung, Internistische Onkologie und Hmatologie mit integire

    Essen, Germany

  • Azienda Ospedaliero - Universitaria di Ferrara

    Cona, Italy

  • Azienda Ospedaliera S. Croce e Carle

    Cuneo, Italy

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy

  • Ospedale Versilia

    Lucca, Italy

  • Azienda USL 2 Lucca

    Lucca, Italy

  • AOU Cagliari-Policlinico Universitario Duilio Casula di Monserrato-UOC Oncologia Medica

    Monserrato, Italy

  • ASL Napoli 1 Centro-Ospedale del Mare

    Naples, Italy

  • Casa Di Cura Polispecialistica Dott Pederzoli

    Peschiera del Garda, Italy

  • AUSL Della Romagna - Ospedale S.Maria delle Croci

    Ravenna, Italy

  • IRCCS Istituto clinico humanitas - Humanitas Mirasole spa

    Rozzano, Italy

  • Azienda Ospedaliera Santa Maria Terni

    Terni, Italy

  • ASST Sette Laghi

    Varese, Italy

  • Raja Perempuan Zainab II Hospital

    Kota Bharu, Kelantan, Malaysia

  • Hospital Canselor Tuanku Muhriz UKM

    Cheras, Kuala Lumpur, Malaysia

  • Hospital Umum Sarawak

    Kuching, Sarawak, Malaysia

  • Clinica Integral Internacional de Oncolgia S de RL de CV

    Puebla City, Mexico

  • Preparaciones Oncolgicas S.C.

    León, Guanajuato, Mexico

Showing 40 of 128 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.